World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
106
Citations
52305
World Ranking
595
National Ranking
297

Research.com Recognitions

  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Mutation

His scientific interests lie mostly in Genetics, Enhancer, Gene, Genome and Human genome. Genetics and Apolipoprotein B are commonly linked in his work. His Enhancer research incorporates themes from Regulation of gene expression, Reporter gene and Conserved sequence.

Len A. Pennacchio combines subjects such as Computational biology and Binding site with his study of Gene. His Genome study incorporates themes from Homeobox and Hox gene. His Human genome study combines topics from a wide range of disciplines, such as Disease and Genomics.

His most cited work include:

  • Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (1951 citations)
  • Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (1951 citations)
  • ChIP-seq accurately predicts tissue-specific activity of enhancers (1335 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Genetics, Gene, Enhancer, Computational biology and Regulation of gene expression. Genetics is a component of his Human genome, Allele, Transgene, Regulatory sequence and Mutation studies. His studies in Allele integrate themes in fields like Internal medicine, Single-nucleotide polymorphism, Genetic association and Genetic variation.

The various areas that Len A. Pennacchio examines in his Enhancer study include Chromatin, Epigenomics, Conserved sequence and Cell biology. His biological study spans a wide range of topics, including Genome, Genomics, Function, Sequence and DNA sequencing. Len A. Pennacchio has included themes like Enhancer RNAs, Histone and Gene expression profiling in his Regulation of gene expression study.

He most often published in these fields:

  • Genetics (93.85%)
  • Gene (68.16%)
  • Enhancer (75.42%)

What were the highlights of his more recent work (between 2018-2021)?

  • Enhancer (75.42%)
  • Gene (68.16%)
  • Transcription factor (26.26%)

In recent papers he was focusing on the following fields of study:

Len A. Pennacchio mostly deals with Enhancer, Gene, Transcription factor, Chromatin and Cell biology. Len A. Pennacchio studied Enhancer and Histone that intersect with Epigenome. His Gene research entails a greater understanding of Genetics.

His Transcription factor research includes themes of Gene knockout, Epigenomics, Penetrance and Cardiac neural crest cells. His Chromatin study integrates concerns from other disciplines, such as Sinoatrial node, Gene expression, DNA methylation and Computational biology. Len A. Pennacchio has researched Computational biology in several fields, including ENCODE, Epigenetics and Genome.

Between 2018 and 2021, his most popular works were:

  • Expanded encyclopaedias of DNA elements in the human and mouse genomes (141 citations)
  • Expanded encyclopaedias of DNA elements in the human and mouse genomes (141 citations)
  • An atlas of dynamic chromatin landscapes in mouse fetal development. (37 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Mutation

His primary areas of investigation include Enhancer, Chromatin, Computational biology, Regulation of gene expression and Gene. His Enhancer research includes elements of Mutation, Sonic hedgehog, Reporter gene, Cell biology and Genome editing. In his study, Methylation, Genomics and Functional genomics is strongly linked to DNA methylation, which falls under the umbrella field of Chromatin.

The Computational biology study combines topics in areas such as Transcription factor, Epigenomics, ENCODE and Promoter. His study looks at the relationship between Regulation of gene expression and fields such as Histone, as well as how they intersect with chemical problems. His biological study focuses on CRISPR.

Best Publications

  • Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

    Stefano Romeo;Julia Kozlitina;Julia Kozlitina;Chao Xing;Alexander Pertsemlidis

  • Expanded encyclopaedias of DNA elements in the human and mouse genomes

    Jill E. Moore;Michael J. Purcaro;Henry E. Pratt;Charles B. Epstein

  • The amphioxus genome and the evolution of the chordate karyotype

    Nicholas H. Putnam;Thomas Butts;David E. K. Ferrier;Rebecca F. Furlong

  • ChIP-seq accurately predicts tissue-specific activity of enhancers

    Axel Visel;Matthew J. Blow;Matthew J. Blow;Zirong Li;Tao Zhang

  • Metagenomic discovery of biomass-degrading genes and genomes from cow rumen.

    Matthias Hess;Matthias Hess;Alexander Sczyrba;Alexander Sczyrba;Rob Egan;Rob Egan;Tae Wan Kim

  • Guidelines for investigating causality of sequence variants in human disease

    D G MacArthur;T A Manolio;D P Dimmock;H L Rehm

  • In vivo enhancer analysis of human conserved non-coding sequences

    Len A. Pennacchio;Len A. Pennacchio;Nadav Ahituv;Alan M. Moses;Shyam Prabhakar

  • An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

    Len A. Pennacchio;Michael Olivier;Jaroslav A. Hubacek;Jonathan C. Cohen

  • VISTA Enhancer Browser—a database of tissue-specific human enhancers

    Axel Visel;Simon Minovitsky;Inna Dubchak;Inna Dubchak;Len A. Pennacchio;Len A. Pennacchio

  • Dicer, Drosha, and outcomes in patients with ovarian cancer

    William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat

  • A common allele on chromosome 9 associated with coronary heart disease

    Ruth Mcpherson;Alexander Pertsemlidis;Nihan Kavaslar;Alexandre Stewart

  • Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

    Bhaswati Pandit;Anna Sarkozy;Len A Pennacchio;Claudio Carta

  • Genomic views of distant-acting enhancers

    Axel Visel;Edward M. Rubin;Edward M. Rubin;Len A. Pennacchio;Len A. Pennacchio

  • Most Rare Missense Alleles Are Deleterious in Humans: Implications for Complex Disease and Association Studies

    Gregory V. Kryukov;Len A. Pennacchio;Len A. Pennacchio;Shamil R. Sunyaev

  • Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants

    Stephen C. J. Parker;Michael L. Stitzel;D. Leland Taylor;Jose Miguel Orozco

  • Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1)

    Len A. Pennacchio;Anna-Elina Lehesjoki;Nancy E. Stone;Virginia L. Willour

  • Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome

    Marco Tartaglia;Len A Pennacchio;Len A Pennacchio;Chen Zhao;Kamlesh K Yadav

  • Enhancers: five essential questions

    Len A. Pennacchio;Wendy Bickmore;Ann Dean;Marcelo A. Nobrega

  • Enhancer redundancy provides phenotypic robustness in mammalian development

    Marco Osterwalder;Iros Barozzi;Virginie Tissières;Virginie Tissières;Yoko Fukuda-Yuzawa

  • Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL

    Stefano Romeo;Len A Pennacchio;Len A Pennacchio;Yunxin Fu;Eric Boerwinkle

Frequent Co-Authors

Axel Visel
Axel Visel Lawrence Berkeley National Laboratory
Edward M. Rubin
Edward M. Rubin Joint Genome Institute
Iros Barozzi
Iros Barozzi Medical University of Vienna
Bing Ren
Bing Ren New York Genome Center
Richard M. Myers
Richard M. Myers HudsonAlpha Institute for Biotechnology
Inna Dubchak
Inna Dubchak Lawrence Berkeley National Laboratory
David Bruce
David Bruce Pebble Labs
Miriam Land
Miriam Land Oak Ridge National Laboratory
Nadav Ahituv
Nadav Ahituv University of California, San Francisco
Matt Nolan
Matt Nolan Lawrence Berkeley National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Genetics opens doors to a variety of healthcare and research careers. Many students may look to expand their skills or explore flexible education routes online. For those interested in nursing, rn to bsn online programs without clinicals offer a convenient pathway for registered nurses aiming to advance their qualifications without extensive in-person requirements.

Nursing professionals seeking leadership and research opportunities might consider accelerated msn to dnp programs, allowing a fast-track route to a Doctor of Nursing Practice degree. Another quick pathway into healthcare is available through medical assistant degree online 6 weeks programs, ideal for those wanting to enter the workforce swiftly.

For advanced roles in healthcare leadership, research, and policy, a dnp online degree can be an excellent next step. These online options support students in balancing their studies with work or family commitments, making genetic and healthcare careers accessible from almost anywhere.

Best Scientists Citing Len A. Pennacchio

Trending Scientists

Recently Published Articles